TY - JOUR
T1 - The evolving role of germline genetic testing and management in prostate cancer
T2 - Report from the princess margaret cancer centre international retreat
AU - Clark, Roderick
AU - Kenk, Miran
AU - McAlpine, Kristen
AU - Thain, Emily
AU - Farncombe, Kirsten M.
AU - Pritchard, Colin C.
AU - Nussbaum, Robert
AU - Wyatt, Alexander W.
AU - de Bono, Johann
AU - Vesprini, Danny
AU - Bombard, Yvonne
AU - Lorentz, Justin
AU - Narod, Steven
AU - Kim, Raymond
AU - Fleshner, Neil
N1 - Publisher Copyright:
© 2021 Canadian Urological Association. All rights reserved.
PY - 2021/6
Y1 - 2021/6
N2 - Introduction: Prostate cancer is a significant cause of cancer mortality. It has been well-established that certain germline pathogenic variants confer both an increased risk of being diagnosed with prostate cancer and dying of prostate cancer.1 There are exciting developments in both the availability of genetic testing and opportunities for improved treatment of patients. On August 19, 2020, the Princess Margaret Cancer Centre in Toronto, Ontario, hosted a virtual retreat, bringing together international experts in urology, medical oncology, radiation oncology, medical genetics, and translational research, as well as a patient representative. We are pleased to provide this manuscript as a review of those proceedings for Canadian clinicians.
AB - Introduction: Prostate cancer is a significant cause of cancer mortality. It has been well-established that certain germline pathogenic variants confer both an increased risk of being diagnosed with prostate cancer and dying of prostate cancer.1 There are exciting developments in both the availability of genetic testing and opportunities for improved treatment of patients. On August 19, 2020, the Princess Margaret Cancer Centre in Toronto, Ontario, hosted a virtual retreat, bringing together international experts in urology, medical oncology, radiation oncology, medical genetics, and translational research, as well as a patient representative. We are pleased to provide this manuscript as a review of those proceedings for Canadian clinicians.
UR - http://www.scopus.com/inward/record.url?scp=85109612055&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109612055&partnerID=8YFLogxK
U2 - 10.5489/CUAJ.7383
DO - 10.5489/CUAJ.7383
M3 - Review article
AN - SCOPUS:85109612055
SN - 1911-6470
VL - 15
JO - Journal of the Canadian Urological Association
JF - Journal of the Canadian Urological Association
IS - 12
ER -